Factor Update, February 8, 2025
This content is for members only
Source link
This content is for members only
Source link
It was a great idea to shift almost all the work — deal management and result tracking — onto the fragile shoulders of a utility. I receive signals from the indicator (which is installed on a VPS), open a trade on the mobile terminal with a simple flick of the wrist, and then I don’t…
Muthukrishnan Dhandapani, a Chennai-based mutual fund distributor, certified financial planner and finfluencer, found himself at the centre of attention on social media platform X after revealing that he has been managing the investment portfolio of Congress leader and Leader of the Opposition in the Lok Sabha, Rahul Gandhi. Apart from being an accomplished financial advisor,…
Some stuff I am reading today morning: US markets decline (CNBC) Further consolidation of PSU Banks (MC) Jio Platforms will be third most valuable co of India (HT) ED summons Anil Ambani again (ML) Tesla shareholders approve Musk’s $1 Trillion package (Yahoo) Tariffs likely to be overturned (Big Picture) Global gold demand rising (BW) Gold’s…
Georgijevic Listen below or on the go on Apple Podcasts and Spotify ByteDance (BDNCE) working with Broadcom (AVGO) on advanced AI chip – report. (00:25) Fast-fashion firm Shein may abandon London IPO – report. (01:16) Freight M&A: UPS sells Coyote Logistics to RXO. (02:23) This is an abridged transcript of the podcast. ByteDance (BDNCE), the…
Market volatility is part and parcel of investing. That’s what generates the above-average returns for investors relative to other asset classes like real estate and fixed income investing. That said, when times get volatile, some investors want to hunker down in safer, more defensive names. Here are two top stocks I think can outperform in…
14th January 2019 – Perth, Australia: PharmAust Limited (ASX: PAA), a clinical stage oncology company that is engaged in collaboration with the Olivia Newton-John Cancer Research Institute (ONJCRI), is pleased to announce important findings confirming anti-cancer activity of monepantel’s major metabolite, monepantel sulfone. The human cancer cell lines tested were representative of cancers that PharmAust…